The National Cancer Institute’s Division of Cancer Epidemiology and Genetics released a summary of 3 studies that have the potential for informing recommendations for anal cancer screening, the importance of early detection, risk and survival in people living with HIV. While anal cancer is fairly rare, the American Cancer Society estimates for anal cancer in the United States for 2023 are about 9,769 new cases (3,180 in men and 6,580 in women). The incidence rate for anal cancer among PLWH is 19-fold greater when compared to the general population (Colon-Lopez V, et al 2018). To date, there are no official anal cancer screening guidelines in the U.S. Read up on these study summaries from NCI DCEG to understand how this impactful, continued research can affect change in the delivery of health care for all.
HIV Malignancy Specimens for Research at No Charge